SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 1 filers reported holding SEATTLE GENETICS INC in Q4 2011. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,414,000 | +51.8% | 22,556 | +31.8% | 0.03% | +24.0% |
| Q2 2020 | $2,907,000 | +7.4% | 17,110 | -27.0% | 0.02% | 0.0% |
| Q1 2020 | $2,706,000 | +29.6% | 23,450 | +28.3% | 0.02% | +56.2% |
| Q4 2019 | $2,088,000 | +24.5% | 18,273 | -7.0% | 0.02% | +14.3% |
| Q3 2019 | $1,677,000 | +32.5% | 19,639 | +7.4% | 0.01% | +27.3% |
| Q2 2019 | $1,266,000 | -33.8% | 18,288 | -30.0% | 0.01% | -35.3% |
| Q1 2019 | $1,912,000 | +42.1% | 26,108 | +9.9% | 0.02% | +21.4% |
| Q4 2018 | $1,346,000 | -27.1% | 23,753 | -0.8% | 0.01% | -12.5% |
| Q3 2018 | $1,847,000 | +16.2% | 23,953 | 0.0% | 0.02% | +14.3% |
| Q2 2018 | $1,590,000 | +26.8% | 23,953 | 0.0% | 0.01% | +27.3% |
| Q1 2018 | $1,254,000 | -5.3% | 23,953 | -3.2% | 0.01% | -8.3% |
| Q4 2017 | $1,324,000 | +4.7% | 24,753 | +6.6% | 0.01% | 0.0% |
| Q3 2017 | $1,264,000 | +19.6% | 23,229 | +13.7% | 0.01% | +20.0% |
| Q2 2017 | $1,057,000 | -25.5% | 20,429 | -9.4% | 0.01% | -28.6% |
| Q1 2017 | $1,418,000 | +23.8% | 22,553 | +3.9% | 0.01% | +16.7% |
| Q4 2016 | $1,145,000 | +400.0% | 21,705 | +410.9% | 0.01% | +500.0% |
| Q3 2016 | $229,000 | +87.7% | 4,248 | +40.5% | 0.00% | 0.0% |
| Q2 2016 | $122,000 | +15.1% | 3,023 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $106,000 | -22.1% | 3,023 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $136,000 | +172.0% | 3,023 | +135.4% | 0.00% | +100.0% |
| Q3 2015 | $50,000 | +108.3% | 1,284 | +159.9% | 0.00% | – |
| Q2 2015 | $24,000 | +41.2% | 494 | 0.0% | 0.00% | – |
| Q1 2015 | $17,000 | -99.4% | 494 | -99.3% | 0.00% | -100.0% |
| Q2 2014 | $2,678,000 | +30.6% | 70,000 | +55.6% | 0.08% | +25.4% |
| Q1 2014 | $2,050,000 | -48.6% | 45,000 | -55.0% | 0.06% | -51.9% |
| Q4 2013 | $3,989,000 | +127.6% | 100,000 | +150.0% | 0.13% | +114.8% |
| Q3 2013 | $1,753,000 | +46.7% | 40,000 | +5.3% | 0.06% | +45.2% |
| Q2 2013 | $1,195,000 | -46.6% | 38,000 | -39.7% | 0.04% | -46.8% |
| Q1 2013 | $2,237,000 | +37.7% | 63,000 | -10.0% | 0.08% | +23.4% |
| Q4 2012 | $1,624,000 | +47.0% | 70,000 | +70.7% | 0.06% | +42.2% |
| Q3 2012 | $1,105,000 | +1.2% | 41,000 | -4.7% | 0.04% | -8.2% |
| Q2 2012 | $1,092,000 | -33.0% | 43,000 | -46.2% | 0.05% | -32.9% |
| Q1 2012 | $1,630,000 | +77.4% | 80,000 | +45.5% | 0.07% | +73.8% |
| Q4 2011 | $919,000 | – | 55,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |